Now, Vyalev (foscarbidopa and foslevodopa) has become the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's ...

Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as alteplase, the traditional stroke treatment, and may even help certain patients ...